Indole-3-carbinol
- Generic Name
- Indole-3-carbinol
- Drug Type
- Small Molecule
- Chemical Formula
- C9H9NO
- CAS Number
- 700-06-1
- Unique Ingredient Identifier
- C11E72455F
- Background
Indole 3 Carbinol is under investigation in clinical trial NCT00033345 (Indole-3-Carbinol in Preventing Breast Cancer in Nonsmoking Women Who Are at High Risk For Breast Cancer).
Trial of Indole-3-Carbinol and Silibinin
- First Posted Date
- 2018-09-27
- Last Posted Date
- 2021-08-11
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 21
- Registration Number
- NCT03687073
- Locations
- 🇺🇸
Masonic Cancer Center at University of Minnesota, Minneapolis, Minnesota, United States
Brassica Vegetables or Indole-3-Carbinol in Treating Patients With PSA Recurrence After Surgery for Prostate Cancer
Not Applicable
Completed
- Conditions
- Prostate Cancer
- Interventions
- Behavioral: behavioral dietary interventionOther: counseling interventionDietary Supplement: Brassica vegetableOther: medical chart reviewOther: questionnaire administrationProcedure: adjuvant therapy
- First Posted Date
- 2008-02-06
- Last Posted Date
- 2016-04-27
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 66
- Registration Number
- NCT00607932
Indole-3-Carbinol in Preventing Cancer in Healthy Participants
Phase 1
Completed
- Conditions
- Unspecified Adult Solid Tumor, Protocol Specific
- First Posted Date
- 2005-01-10
- Last Posted Date
- 2008-07-24
- Lead Sponsor
- University of Kansas
- Registration Number
- NCT00100958
- Locations
- 🇺🇸
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center, Kansas City, Kansas, United States
Indole-3-Carbinol in Preventing Breast Cancer in Nonsmoking Women Who Are at High Risk For Breast Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2016-08-18
- Lead Sponsor
- University of Kansas Medical Center
- Target Recruit Count
- 17
- Registration Number
- NCT00033345
- Locations
- 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath